GF CSI Medical Service ETF(560260) Rises 0.60%, Latest AUM Reaches 1.538 Billion Yuan

NewTimeSpace News, as of 14:23 on April 22, 2026, GF Medical ETF (560260) rose 0.60%, with its latest quoted price at 0.84 yuan. Looking at a longer timeframe, as of April 21, 2026, GF Medical ETF gained 0.60% over the past two weeks, ranking 1/4 among comparable funds in terms of increase. (The stocks listed above are merely index constituents and do not constitute any specific recommendation.)

In terms of liquidity, GF Medical ETF recorded an intraday turnover rate of 0.25%, with a trading volume of 3.8059 million yuan. Over a longer horizon, as of April 21, the ETF's average daily turnover over the past year stood at 12.2406 million yuan.

Regarding scale, the latest AUM of GF Medical ETF reached 1.538 billion yuan. (Data source: Wind)

In terms of share size, GF Medical ETF's share count increased by 3.00 million units over the past month, achieving significant growth, with the new share increment ranking 2/4 among comparable funds. (Data source: Wind)

As of April 21, GF Medical ETF's net value increased by 7.54% over the past two years. In terms of return capability, as of April 21, 2026, since its inception, the ETF achieved a highest single-month return of 29.94%, a longest consecutive gaining streak of five months with a cumulative gain of 24.01%, and an average return of 6.78% during up months. As of April 21, 2026, the ETF's annualized excess return over its benchmark over the past year was 1.51%.

In terms of drawdown, as of April 21, 2026, GF Medical ETF's relative drawdown versus its benchmark since the beginning of the year was 0.07%.

In terms of fees, GF Medical ETF has a management fee rate of 0.50% and a custody fee rate of 0.05%, which are at a relatively low level among comparable funds.

In terms of tracking accuracy, as of April 21, 2026, GF Medical ETF's six-month tracking error was 0.016%, the highest tracking precision among comparable funds.

From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI Medical Index, which GF Medical ETF tracks, is only 29.01 times, placing it at the 4.3rd percentile over the past year—meaning the valuation is lower than that of over 95.7% of the time in the past year, indicating a historically low level.

GF Medical ETF closely tracks the CSI Medical Index. The CSI Medical Index selects securities of listed companies in the healthcare and pharmaceutical industry whose businesses involve medical themes such as medical devices, medical services, and medical information technology as index constituents, in order to reflect the overall performance of listed company securities in the medical theme.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.